GlassScriptPhysician profile
Daniel Torres Leyva
NPI 1619388667
$47,122.54
in general payments reported to CMS, 2019-2025
30 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $1,729 · 2021: $3,393 · 2022: $14K · 2023: $4,596 · 2024: $8,172 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $11K · Travel and Lodging: $1,163 · Education: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,782.03 |
| Consulting Fee | $11,038.50 |
| Travel and Lodging | $1,162.84 |
| Education | $362.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14,114.26 | 2019-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $7,446.30 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $5,328.48 | 2019-2025 | |
| Amgen INC. | $5,278.82 | 2020-2025 | Tavneos, Enbrel, Evenity |
| Abbvie INC. | $4,754.09 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Pfizer INC. | $1,914.43 | 2019-2025 | |
| Lilly USA, LLC | $1,383.13 | 2019-2024 | Taltz, Zepbound |
| Horizon Therapeutics Plc | $1,253.56 | 2019-2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $727.78 | 2021-2025 | Saphnelo |
| Radius Health, INC. | $708.26 | 2019-2025 | Tymlos |
| Ani Pharmaceuticals, INC. | $502.36 | 2022-2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $489.13 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.59 | 2022-2025 | Ofev, Cyltezo |
| Genentech USA, INC. | $423.07 | 2019-2025 | Actemra, Rituxan |
| Glaxosmithkline, LLC. | $333.79 | 2020-2024 | Benlysta |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $320.88 | 2022-2025 | Lupkynis |
| Janssen Pharmaceuticals, INC | $264.79 | 2025 | Tremfya |
| Fidia Pharma USA INC. | $264.59 | 2023-2025 | Hym/Hyn, Hymhyn |
| Ferring Pharmaceuticals INC. | $222.06 | 2021-2024 | Euflexxa |
| Mallinckrodt Hospital Products INC. | $179.12 | 2020-2023 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $135.74 | 2022-2025 | Orencia, Sotyktu |
| Janssen Scientific Affairs, LLC | $124.77 | 2021 | |
| Cardinal Health 110 LLC | $100.00 | 2022 | |
| Sandoz INC. | $97.95 | 2024-2025 | Hyrimoz |
| Mallinckrodt Enterprises LLC | $79.97 | 2019 | |
| Sobi, INC | $67.92 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $67.30 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $45.99 | 2024 | Arcalyst |
| Zimmer Biomet Holdings, INC. | $24.27 | 2024 | |
| Almatica Pharma LLC | $23.14 | 2025 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Torres Leyva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.